[HTML][HTML] Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
E Kipps, DSP Tan, SB Kaye - Nature Reviews Cancer, 2013 - nature.com
Malignant ascites presents a considerable clinical challenge to the management of ovarian
cancer, but also provides a wealth of opportunities for translational research. The …
cancer, but also provides a wealth of opportunities for translational research. The …
The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer
CP Carden, A Stewart, P Thavasu, E Kipps… - Molecular cancer …, 2012 - AACR
Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer
is largely based on the analysis of surgical specimens sampled at diagnosis and may not …
is largely based on the analysis of surgical specimens sampled at diagnosis and may not …
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study
…, SA Boyce, M Williams, C Barry, E Riboli, E Kipps… - Gut, 2021 - gut.bmj.com
Objective To evaluate the impact of faecal immunochemical testing (FIT) prioritisation to
mitigate the impact of delays in the colorectal cancer (CRC) urgent diagnostic (2-week-wait (…
mitigate the impact of delays in the colorectal cancer (CRC) urgent diagnostic (2-week-wait (…
To cycle or fight—CDK4/6 inhibitors at the crossroads of anticancer immunity
M Ameratunga, E Kipps, AFC Okines, JS Lopez - Clinical Cancer Research, 2019 - AACR
Dysregulation of cell division resulting in aberrant cell proliferation is a key hallmark of
cancer, making it a rational and important target for innovative anticancer drug development. …
cancer, making it a rational and important target for innovative anticancer drug development. …
Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy
E Kipps, K Young, N Starling - Therapeutic advances in …, 2017 - journals.sagepub.com
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease. The majority of patients are
diagnosed with locally advanced or metastatic disease with a prognosis of short months. …
diagnosed with locally advanced or metastatic disease with a prognosis of short months. …
The 'hub and spoke model'for the management of surgical patients during the COVID‐19 pandemic
…, P Gruber, D Nicol, D Morgan, E Kipps… - … Journal of Health …, 2021 - Wiley Online Library
During the on‐going COVID‐19 pandemic a number of key public health services have
been severely impacted. These include elective surgical services due to the synergetic …
been severely impacted. These include elective surgical services due to the synergetic …
[HTML][HTML] Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital
…, KA Lee, M Allen, S Johnston, E Kipps… - Breast Cancer Research …, 2022 - Springer
Purpose To describe the tolerability and efficacy of neratinib as a monotherapy and in
combination with capecitabine in advanced HER2-positive breast cancer in a real-world setting. …
combination with capecitabine in advanced HER2-positive breast cancer in a real-world setting. …
[HTML][HTML] Patient factors and their impact on neutropenic events: a systematic review and meta-analysis
P Chambers, Y Jani, L Wei, E Kipps, MD Forster… - Supportive Care in …, 2019 - Springer
Background Neutropenia is associated with an increased risk of mortality and hospitalisation.
Strategies, including the prescribing of colony-stimulating growth factors (CSFs), are …
Strategies, including the prescribing of colony-stimulating growth factors (CSFs), are …
Non-motor symptoms in Parkinson's disease: an underdiagnosed problem
S Muzerengi, H Lewis, M Edwards, E Kipps, A Bahl… - 2006 - Future Medicine
Parkinson's disease results from degeneration of the substantia nigra pars compacta and
the consequent dysfunction of the dopaminergic nigrostriatal pathway. Serotonergic and …
the consequent dysfunction of the dopaminergic nigrostriatal pathway. Serotonergic and …